Federation Des Caisses Desjardins Du Quebec Gamida Cell Ltd. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $13.8 Trillion
  • Q1 2024
Number of Shares
0
Holding current value
$0
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.04 - $0.46 $0 - $0
0 New
0 $0
Q1 2024

May 15, 2024
BUY
$0.04 - $0.46 $0 - $0
0 New
0 $0

Others Institutions Holding GMDA

# of Institutions
58
Shares Held
11.4M
Call Options Held
235K
Put Options Held
70.5K
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email